Atsushi Hagino

No ORCID on file · 2 papers in corpus
rct 2017
Fertility and sterility ·doi:10.1016/j.fertnstert.2017.07.021

OBJECTIVE: To evaluate the efficacy and safety of dienogest (DNG), a progestational 19-norsteroid, in patients with symptomatic adenomyosis. DESIGN: Phase III, randomized, double-blind, multicenter, placebo-controlled study. SETTING: Clin…

nonrandomized-trial 2017
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/jog.13406

AIM: We aimed to investigate the safety and efficacy of dienogest (DNG), a progestational 19-norsteroid, administered for 52 weeks in patients with symptomatic adenomyosis. METHODS: A total of 130 patients with adenomyosis received 2 mg of…